Paper Details

  1. Home
  2. Paper Details

Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids.

Author: AhmadShaleen, BeggsSean, KewKayleigh M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Asthma is a common chronic condition in children, often leading to preventable attacks that require extra treatment. Inhaled corticosteroids (ICS) are the first-line treatment, and when symptoms aren't well-controlled, long-acting beta2-agonists (LABAs) are often added. However, there is a warning about using LABAs for as short a time as possible, stopping them once asthma is controlled.
Paper Details　
Original Abstract of the Article :
Asthma is the most common chronic medical condition among children and is one of the most common causes of hospitalisation and medical visits. Poorly controlled asthma often leads to preventable exacerbations that require additional medications, hospital stays, or treatment in the emergency departme...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486153/

データ提供：米国国立医学図書館（NLM）

Long-Acting Beta2-Agonists (LABA) for Asthma in Children: A Balancing Act

This study explores the complexities of asthma management in children, focusing on the use of long-acting beta2-agonists (LABA) as an add-on treatment for poorly controlled asthma. While LABAs are highly effective in managing asthma symptoms, their use has been associated with potential risks, leading to recommendations for careful monitoring and minimizing treatment duration. This study investigates the potential for safely discontinuing LABAs in children with well-controlled asthma, balancing the need for effective symptom management with the need to minimize potential risks.

Balancing Asthma Control and LABA Discontinuation

The study emphasizes the importance of achieving well-controlled asthma in children with LABA and inhaled corticosteroids (ICS). The researchers advocate for discontinuing LABAs as soon as possible once asthma control is achieved, minimizing the duration of exposure to potential risks while ensuring effective symptom management. This research highlights the importance of individualized care, closely monitoring asthma control and adjusting treatment strategies accordingly.

Navigating Asthma: A Journey Through Wheezing and Coughing

Asthma can be a challenging condition for children, affecting their daily lives and overall well-being. This study offers valuable insights into the delicate balance between managing asthma symptoms and minimizing potential risks associated with LABA use. It's like navigating a desert path—while the path may be long and winding, with careful planning and attention to detail, it's possible to reach the destination safely. This research underscores the importance of a proactive approach to asthma management, ensuring that children receive the most effective and safe treatment possible.

Dr.Camel's Conclusion

This study emphasizes the importance of individualized care in asthma management, focusing on achieving optimal asthma control while minimizing the duration of LABA use. It's like finding the perfect balance in a desert oasis—using the resources available to navigate the journey effectively, while minimizing potential risks. This research highlights the importance of ongoing monitoring and adjustments to treatment strategies to ensure the best possible outcomes for children with asthma.
Date :
  1. Date Completed 2015-10-30
  2. Date Revised 2023-08-15
Further Info :

Pubmed ID

25997166

DOI: Digital Object Identifier

PMC6486153

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.